1Regitz V,Shug AL,Fleck E.Defective myocardial carnitine metabolism in congestive heart failure secondary to dilated cardiomyopathy and to coronary,hypert ensive and valvular heart diseases[J].Am J Cardiol,1990,65(11):755-760.
2Charles J,Rebouche.Carnitine metabolism and its regulation in micro-organism and mammals[J].Annu Rev Nutr,1998:39-61.
5Minamino T, Kitakaze M, Rast P J, et al. Inhibition of nitric oxide synthesis induces coronary vascular remodeling and cardiac hypertrophy associated with the activation of p70 S6 kinase in rats[J]. Cardiovasc Drugs Ther 2000,14(5) :533 - 542.
6Groenning B A, Nilsson J C, Sondergaard L, et al. Antiremodeling effects on the left ventricle during, heta - blockade with metoprolol in the treatment of chronic heart failure[J ]. J Am Coil Cardiol, 2000,36 (7) : 2072 - 2080.
7Weber K T,Brilla C G. Pathological hypertrophy and cardiac interstitium: Fibrosis and renin - angiotensin- aldosterone system[ J ]. Circulation, 1991,83(6) : 1849.
8Schmier R E, Martus P, Klingbeil A. Reversal of left ventricular hypertrophy in essential hypertension [J ]. J AMA, 1996, 275 ( 19 ) :1507 - 1513.
9Nilsson J C, Groenning B A, Nielsen G, et al. Left ventricular remodeling in the first year after acute myocardial infarction and the predictive and the predictive value of N - terminal pro brain natriuretic peptide[J]. Am Heart J, 2002,143(4) :496 - 702.
10Levine B, Kalman J, Fillit H M, et al. Elevated circulating of tumor necrosis factor in severe chronic heart failure [J]. N Engl J Med,1990, 323:236- 241.
